Palivizumab, nabava za 2025.- 2027. godinu
TED · 533483-2026Award noticeawardedNo deadline given
Value
Estimated€7,248,690 · 7,248,690 EUR
Awarded€2,416,230 · 2,416,230 EUR
WinnerOKTAL PHARMA d.o.o.
Who already wins at this buyer
Firms with recorded awards from Hrvatski zavod za javno zdravstvo in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| PHOENIX Farmacija d.o.o. | 8 | €4,282,025 | 2026-08-03 |
| MEDOKA d.o.o. | 6 | €2,360,870 | 2026-08-03 |
| MEDIKA, d.d. | 3 | €4,621,368 | 2026-08-03 |
| Pfizer Export B.V. | 1 | €1,305,875 | 2026-08-03 |
| BIOSPECTRA D.O.O. | 1 | €323,680 | 2026-07-30 |
Full buyer profile: what Hrvatski zavod za javno zdravstvo buys and who wins it →
CPV codes
33651600 Medical equipment & pharmaceuticalsDescription
Palivizumab, nabava za 2025. - 2027. godinu
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-08-03 | Cjepivo protiv gripe, inaktivirano, nabava za 2025-2027. godinu | Hrvatski zavod za javno zdravstvo HR | 94% |
| 2026-08-03 | Cjepivo protiv poliomijelitisa, inaktivirano, nabava za 2025-2027. godinu | Hrvatski zavod za javno zdravstvo HR | 94% |
| 2026-08-03 | Cjepivo protiv pneumokoka, polisaharidno, nabava za 2025.-2027. godinu | Hrvatski zavod za javno zdravstvo HR | 94% |
| 2026-08-03 | Cjepivo protiv meningokoka grupe B, nabava za 2025.-2027. godinu | Hrvatski zavod za javno zdravstvo HR | 94% |
| 2026-08-03 | Cjepivo protiv morbila, parotitisa i rubele, živo, nabava za 2025-2027. godinu | Hrvatski zavod za javno zdravstvo HR | 93% |
| 2026-08-03 | Cjepivo protiv humanog papilomavirusa, rekombinantno, adsorbirano, nabava za 2025-2027. godinu | Hrvatski zavod za javno zdravstvo HR | 93% |